Specific alterations of regional myocardial work in strength-trained athletes using anabolic androgenic steroids compared to athletes with genetic hypertrophic cardiomyopathy

• Hauptverfasser: Antoine Grandperrin (VerfasserIn), Frédéric Schnell (VerfasserIn), Erwan Donal (VerfasserIn), Elena Galli (VerfasserIn), Christophe Hedon (VerfasserIn), Olivier Cazorla (VerfasserIn), Stéphane Nottin (VerfasserIn)
• Format: Buch
• Veröffentlicht: Elsevier, 2023-07-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: Strength-trained athletes using anabolic androgenic steroids (AAS) have left ventricular (LV) hypertrophy and myocardial fibrosis that can lead to sudden cardiac death. A similar feature was described in athletes with hypertrophic cardiomyopathy (HCM), which complicates the diagnosis for...